LMO2 confers value as a potential immunotherapy marker in pan-cancer analysis and inhibits progression of Clear Cell Renal Cell Carcinoma

LMO2 confers value as a potential immunotherapy marker in pan-cancer analysis and inhibits progression of Clear Cell Renal Cell Carcinoma

Background: Emerging evidence highlights LIM-domain only 2 (LMO2) as both a potential biomarker and therapeutic target in diverse cancers. However, its functional characterization and clinical significance remain insufficiently explored in cancers such as Clear Cell Renal Cell Carcinoma (ccRCC). The...

Full description

Saved in:
Bibliographic Details
Main Authors: Huiping Wang, Cong Wang, Jia Wei, Xuan’er Zhao, Xuemei Yang, Renren Li, Mengmeng Li, Zhansheng Zhu
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Translational Oncology
Subjects:
Lim-domain only 2
Bioinformatics
Prognosis
Cancer immunity
m6A
BEX-1
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523325001408
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items